Fungal Meningitis

States: More federal help needed in compounding pharmacy oversight

States: More federal help needed in compounding pharmacy oversight

Brought together by the recent outbreak of fungal meningitis, state regulators sought action from the U.S. Food and Drug Administration to regulate compounding pharmacies. The requests came in a Dec. 19 meeting convened by the FDA with representatives from all 50 states.

Don't miss any McKnight's news

Featured Articles